Phase II trial of clinical activity and safety of ceritinib combined with stereotactic ablative radiotherapy (SABR) in lung adenocarcinoma patients.

被引：0
|
作者：
Khan, Saad A.
Gerber, David E.
Zhu, Hong
Hughes, Randall S.
Mannala, Samantha
Rashdan, Sawsan
Dowell, Jonathan
Westover, Kenneth D.
Saltarski, Jessica
Harrah, Kasia
Priddy, Laurin
Choy, Hak
Timmerman, Robert D.
Brekken, Rolf A.
Sorrelle, Noah
Iyengar, Puneeth
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Texas Southwestern, Irving, TX USA
[3] Univ Texas Southwestern Med Ctr, Ft Worth, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21571
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Phase II trial of pre-operative stereotactic ablative radiotherapy (SABR) in early-stage breast cancer
    Liveringhouse, C. L.
    Diaz, R.
    Ahmed, K. A.
    Lee, M. C.
    Czerniecki, B.
    Laronga, C.
    Khakpour, N.
    Weinfurtner, R. J.
    Rosa, M.
    Montejo, M. E.
    CANCER RESEARCH, 2019, 79 (04)
  • [22] Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer.
    Hannan, Raquibul
    Christensen, Michael
    Garant, Aurelie
    Hammers, Hans J.
    Arafat, Waddah
    Courtney, Kevin Dale
    Bowman, Isaac Alex
    Cole, Suzanne
    Sher, David
    Ahn, Chul
    Timmerman, Robert D.
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.
    Hannan, Raquibul
    Christensen, Michael
    Robles, Liliana
    Christie, Alana
    Garant, Aurelie
    Desai, Neil Bipinchandra
    Hammers, Hans J.
    Arafat, Waddah
    Bowman, Isaac Alexander
    Cole, Suzanne
    Courtney, Kevin Dale
    Woldu, Solomon L.
    Bagrodia, Aditya
    Margulis, Vitaly
    Cadeddu, Jeffrey A.
    Choy, Hak
    Sher, David
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [24] Lung Stereotactic Ablative Radiotherapy (SABR) Following Pneumonectomy: A Systematic Review of Clinical and Toxicity Outcomes
    Arifin, A. J.
    Al-Shafa, F.
    Boldt, G.
    Warner, A.
    Rodrigues, G.
    Palma, D. A.
    Louie, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 252 - 253
  • [25] A Phase II Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cell Cancer
    McLaughlin, M.
    Kapur, P.
    Pedrosa, I.
    Ahn, C.
    Robles, L.
    Garant, A.
    Brugarolas, J.
    Woldu, S.
    Bagrodia, A.
    Choy, H.
    Gahan, J.
    Margulis, V.
    Timmerman, R. D.
    Cadeddu, J.
    Hannan, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E865 - E866
  • [26] Spatial Assessment of Dose Distributions for Patients with Lung Cancer Treated with Stereotactic Ablative Radiotherapy (SABR)
    Liu, D.
    Chen, D.
    Chetvertkov, M.
    Altman, M.
    Li, H.
    Wen, N.
    Glide-Hurst, C.
    Ajlouni, M.
    Levin, K.
    Movsas, B.
    Chetty, I.
    MEDICAL PHYSICS, 2012, 39 (06) : 3817 - 3817
  • [27] EARLY DETECTION OF RECURRENCE IN PATIENTS TREATED WITH LUNG STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) USING RADIOMICS
    Kunkyab, Tenzin
    Mou, Benjamin
    Jirasek, Andrew
    Haston, Christina
    Andrews, Jeffrey
    Thomas, Steven
    Hyde, Derek
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S31 - S31
  • [28] Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
    David A Palma
    Cornelis J A Haasbeek
    George B Rodrigues
    Max Dahele
    Michael Lock
    Brian Yaremko
    Robert Olson
    Mitchell Liu
    Jason Panarotto
    GwendolynHMJ Griffioen
    Stewart Gaede
    Ben Slotman
    Suresh Senan
    BMC Cancer, 12
  • [29] Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
    Palma, David A.
    Haasbeek, Cornelis J. A.
    Rodrigues, George B.
    Dahele, Max
    Lock, Michael
    Yaremko, Brian
    Olson, Robert
    Liu, Mitchell
    Panarotto, Jason
    Griffioen, Gwendolyn H. M. J.
    Gaede, Stewart
    Slotman, Ben
    Senan, Suresh
    BMC CANCER, 2012, 12
  • [30] RIFLE: a Phase II trial of stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer
    Wang, Kun
    Chen, Yajie
    Zhang, Zhiyuan
    Wu, Ruiyan
    Zhou, Menglong
    Yang, Wang
    Wan, Juefeng
    Shen, Lijun
    Zhang, Hui
    Wang, Yan
    Han, Xu
    Wang, Jiazhou
    Zhang, Zhen
    Xia, Fan
    GASTROENTEROLOGY REPORT, 2023, 11
12345